Idealab AZ, Inc. is offering $20,000,000 in restricted common stock, with $1,250,000 already sold. Investors can see that $18,750,000 remains in the stated offering, while the notice identifies the technology category and the corporation’s executive officers and directors.
Key Highlights
- $1,250,000 has been sold from Idealab AZ’s exempt securities offering.
- $18,750,000 is listed as the remaining portion of the offering.
- Idealab AZ lists 3219 East Camelback Road, Suite 812, Phoenix, Arizona 85,018 as its address.
Idealab AZ, Inc. is offering $20,000,000 in restricted common stock through an exempt securities offering. The Delaware corporation’s stated offering amount includes $1,250,000 already sold, leaving $18,750,000 identified as the remaining portion.
Technology Offering Names Corporate Leadership
Jonathan Cohen is identified as executive officer, director and chief innovation officer. Allen Morgan is listed as executive officer, director and CEO. William Gross, Chris Camacho and Sam Bradley are identified as directors. The filing includes August 18, 2026. The security is described as restricted common stock.
$18.75M Remains in Stated Offering
The reported sold amount is $1,250,000 against the total offering size of $20,000,000. The balance shown for the offering is $18,750,000. Jonathan Cohen signed for Idealab AZ, Inc. on August 25, 2026, in his capacity as chief innovation officer.



Please wait processing your request...